Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey | Synapse
March 3, 2026Open Access
Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
Key Points
PET is an essential tool in diagnosing brain tumours, aiding in both treatment planning and monitoring.
The survey collected data across various European institutions, highlighting discrepancies in PET availability.
Assessment included feedback on clinical guidelines for PET use in brain tumour management within the EORTC framework.
Findings indicate a need for standardization in PET application among brain tumour specialists across Europe.